Bioprinting of organs for toxicology testing

Hyun Wook Kang, Anthony Atala, James J. Yoo

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Toxicology testing of new drugs is generally performed in animal models. While this traditional approach is instrumental in gaining valuable information from an in vivo model, a number of issues arise with this type of testing such as questionable results, a large financial investment, and ethical considerations. Alternative approaches to animal testing include the use of organoids, which are biological models for specific organs or tissues that are composed of living cells or biomaterials. The organoid should have similar functionality with the native organ or tissue for toxicology testing to be successful. Bioprinting allows for the production of a designed architecture consisting of multiple types of living cells in combination with a variety of biomaterials and can be used in the construction of an organoid that mimics the native organ or tissue. In this chapter, bioprinting technology and its application for the development of new organoids will be discussed.

Original languageEnglish (US)
Title of host publicationEssentials of 3D Biofabrication and Translation
PublisherElsevier Inc.
Pages179-186
Number of pages8
ISBN (Print)9780128010150, 9780128009727
DOIs
StatePublished - Aug 7 2015
Externally publishedYes

Fingerprint

Bioprinting
Organoids
Toxicology
Testing
Biocompatible Materials
Tissue
Animal Testing Alternatives
Animals
Cells
Biological Models
Animal Models
Technology
Pharmaceutical Preparations

Keywords

  • Animal model
  • Bioprinting
  • Organoid
  • Toxicology testing

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kang, H. W., Atala, A., & Yoo, J. J. (2015). Bioprinting of organs for toxicology testing. In Essentials of 3D Biofabrication and Translation (pp. 179-186). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800972-7.00010-4

Bioprinting of organs for toxicology testing. / Kang, Hyun Wook; Atala, Anthony; Yoo, James J.

Essentials of 3D Biofabrication and Translation. Elsevier Inc., 2015. p. 179-186.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kang, HW, Atala, A & Yoo, JJ 2015, Bioprinting of organs for toxicology testing. in Essentials of 3D Biofabrication and Translation. Elsevier Inc., pp. 179-186. https://doi.org/10.1016/B978-0-12-800972-7.00010-4
Kang HW, Atala A, Yoo JJ. Bioprinting of organs for toxicology testing. In Essentials of 3D Biofabrication and Translation. Elsevier Inc. 2015. p. 179-186 https://doi.org/10.1016/B978-0-12-800972-7.00010-4
Kang, Hyun Wook ; Atala, Anthony ; Yoo, James J. / Bioprinting of organs for toxicology testing. Essentials of 3D Biofabrication and Translation. Elsevier Inc., 2015. pp. 179-186
@inbook{16d7a25b6ce3423dadf34a7e1241d426,
title = "Bioprinting of organs for toxicology testing",
abstract = "Toxicology testing of new drugs is generally performed in animal models. While this traditional approach is instrumental in gaining valuable information from an in vivo model, a number of issues arise with this type of testing such as questionable results, a large financial investment, and ethical considerations. Alternative approaches to animal testing include the use of organoids, which are biological models for specific organs or tissues that are composed of living cells or biomaterials. The organoid should have similar functionality with the native organ or tissue for toxicology testing to be successful. Bioprinting allows for the production of a designed architecture consisting of multiple types of living cells in combination with a variety of biomaterials and can be used in the construction of an organoid that mimics the native organ or tissue. In this chapter, bioprinting technology and its application for the development of new organoids will be discussed.",
keywords = "Animal model, Bioprinting, Organoid, Toxicology testing",
author = "Kang, {Hyun Wook} and Anthony Atala and Yoo, {James J.}",
year = "2015",
month = "8",
day = "7",
doi = "10.1016/B978-0-12-800972-7.00010-4",
language = "English (US)",
isbn = "9780128010150",
pages = "179--186",
booktitle = "Essentials of 3D Biofabrication and Translation",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Bioprinting of organs for toxicology testing

AU - Kang, Hyun Wook

AU - Atala, Anthony

AU - Yoo, James J.

PY - 2015/8/7

Y1 - 2015/8/7

N2 - Toxicology testing of new drugs is generally performed in animal models. While this traditional approach is instrumental in gaining valuable information from an in vivo model, a number of issues arise with this type of testing such as questionable results, a large financial investment, and ethical considerations. Alternative approaches to animal testing include the use of organoids, which are biological models for specific organs or tissues that are composed of living cells or biomaterials. The organoid should have similar functionality with the native organ or tissue for toxicology testing to be successful. Bioprinting allows for the production of a designed architecture consisting of multiple types of living cells in combination with a variety of biomaterials and can be used in the construction of an organoid that mimics the native organ or tissue. In this chapter, bioprinting technology and its application for the development of new organoids will be discussed.

AB - Toxicology testing of new drugs is generally performed in animal models. While this traditional approach is instrumental in gaining valuable information from an in vivo model, a number of issues arise with this type of testing such as questionable results, a large financial investment, and ethical considerations. Alternative approaches to animal testing include the use of organoids, which are biological models for specific organs or tissues that are composed of living cells or biomaterials. The organoid should have similar functionality with the native organ or tissue for toxicology testing to be successful. Bioprinting allows for the production of a designed architecture consisting of multiple types of living cells in combination with a variety of biomaterials and can be used in the construction of an organoid that mimics the native organ or tissue. In this chapter, bioprinting technology and its application for the development of new organoids will be discussed.

KW - Animal model

KW - Bioprinting

KW - Organoid

KW - Toxicology testing

UR - http://www.scopus.com/inward/record.url?scp=84940771019&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940771019&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800972-7.00010-4

DO - 10.1016/B978-0-12-800972-7.00010-4

M3 - Chapter

SN - 9780128010150

SN - 9780128009727

SP - 179

EP - 186

BT - Essentials of 3D Biofabrication and Translation

PB - Elsevier Inc.

ER -